(Pre-)clinical
Development
Affectis benefits from its immediate access to the extensive pre-clinical and clinical development know-how and infrastructure of the Max-Planck-Institute and the related psychiatric hospital specialized in depression. The company, therefore, has the prerequisites to conduct advanced development of its compounds at world class standards.
Affectis benefits from its immediate access to the extensive pre-clinical and clinical development know-how and infrastructure of the Max-Planck-Institute and the related psychiatric hospital specialized in depression. The company, therefore, has the prerequisites to conduct advanced development of its compounds at world class standards.